Revenue grew 4.9% but operating cash flow collapsed 63% and FCF turned negative

Operating cash flow fell 63.3% to $11.1m (FY22: $30.2m), and free cash flow before lease payments swung from a $21.8m inflow to a $7.6m outflow. Cash on the balance sheet dropped 44.6% to $21.7m.

Underlying EBITDA fell to $42.2m from $54.4m (per the release), PBT declined 25.1% to $31.4m, and NPAT declined 29.9% to $23.2m. The NPAT fall is amplified by the effective tax rate moving to 26.0% from 21.0%; the cleaner operating read is the 25.1% PBT decline.

Capex more than doubled to $18.7m (+121%), lifting capex intensity from 4.9% to 10.4% of revenue. Gross borrowings were paid down to $5.2m from $16.0m, and a 1.5 cents per share final dividend was declared under the new policy.

OCF/EBITDA fell to 26.3% from 55.6%, and working capital absorbed roughly $15.0m as receivable days extended to 84.5 from 68.1 and inventory days rose to 126.7 from 121.7. The release attributes the inventory build to supply-chain resilience and inflation, but the receivables stretch is not explained. This matters because revenue growth this year was funded by the balance sheet rather than converted to cash.

Free cash flow is negative even before lease payments. With capex up $10.2m and OCF down $19.1m, FCF pre-lease was -$7.6m, so FCF/NPAT was -32.7%. The 1.5 cps dividend equates to a 14.7% payout of NPAT but is not covered by free cash flow at all; it is being paid out of the prior cash pile.

Earnings declined despite revenue growth. PBT fell 25.1% on only 4.9% revenue growth, which implies meaningful operating-cost build — consistent with the release's reference to "increased investment in growth initiatives." ROE fell to 14.8% from 24.5%, reflecting both lower NPAT and a larger equity base.

What can be observed is the half-year shape: HY23 delivered 48.3% of full-year revenue but 66.5% of EBITDA and 69.0% of NPAT, implying a materially weaker second half (implied H2 EBITDA $14.1m, implied H2 NPAT $7.2m). Operating cash flow was essentially nil at the half ($0.0m) and reached $11.1m for the year, so the second-half cash performance was the better period in isolation but still well below the prior year.

This release does not support an inference that earnings momentum is rebuilding into FY24; it supports a read that the second half was the weaker earnings half while capex spend accelerated.

The PBT decline is real operating compression, not a one-off — there is no discontinued operation or disclosed non-recurring item explaining the gap. The further drop to NPAT is partly tax-rate normalisation (26.0% vs 21.0%), which is a presentational distortion rather than an operating one.

Cash quality is the bigger concern. The full $19.1m fall in OCF and the $7.6m FCF outflow are driven by working-capital absorption ($15.0m) and a near-doubling of capex. Inventory build for supply-chain resilience may be deliberate and partly reversible, but receivable days extending 16.4 days is harder to characterise as a strategic choice. The dividend is funded from prior balance-sheet cash rather than current-year free cash flow, which is sustainable only while the cash buffer holds or until capex moderates.

The investment phase is visible: capex at 10.4% of revenue versus 4.9% prior, growth-driven opex, and borrowings repaid. Whether that investment converts into FY24 earnings is the open question.

This briefing cannot assess forward earnings trajectory, customer-concentration risk, or the expected return on the elevated capex programme because no FY24 guidance, forward-work backlog, or project-economics disclosure is supplied in this release.